MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 25.02.2026
MiMedx Group Betriebsaufwand 2011-2026 | MDXG
Betriebsaufwand Jährlich MiMedx Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 277 M | 327 M | 240 M | 194 M | 143 M | 98.5 M | 52.1 M | 23.9 M | 14.4 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 327 M | 14.4 M | 152 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
614 M | $ 11.08 | 1.65 % | $ 1.66 B |  USA |
 |
AxoGen
AXGN
|
121 M | $ 32.13 | 0.53 % | $ 1.48 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 177.98 | 2.79 % | $ 13.3 B | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.21 | 0.33 % | $ 1.65 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.58 | -5.66 % | $ 36.1 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 285.13 | 2.15 % | $ 8.04 B | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.32 | 0.61 % | $ 124 M |  France |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 38.63 | 2.77 % | $ 5.76 K | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 62.5 | 1.2 % | $ 92.5 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.54 | 9.91 % | $ 270 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.92 | 1.32 % | $ 1.17 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
40.3 M | $ 24.33 | 0.95 % | $ 206 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.0 | 0.31 % | $ 16.9 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.5 | 2.61 % | $ 173 M | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
697 M | $ 63.6 | 1.3 % | $ 3.47 B |  Britain |
 |
LENSAR
LNSR
|
32.6 M | $ 5.8 | 1.75 % | $ 69.4 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.71 | 4.63 % | $ 392 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 92.05 | 1.86 % | $ 12.4 B | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.12 | 0.37 % | $ 872 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.24 | 1.99 % | $ 367 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.7 | 1.88 % | $ 29.3 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 54.26 | 0.48 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 37.51 | 2.1 % | $ 1.16 B | USA |
 |
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 86.31 | 1.37 % | $ 3 B | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.67 | -0.05 % | $ 122 M | USA |